Gamida Cell Gears Up For Omidubicel Submission
Seeks Partners For Bone Marrow Transplant Cell Therapy
With funding drying up for biotechs as sentiment continues to turn against the sector, Israel-headquartered Gamida Cell is cutting jobs and putting out feelers for potential partners to take its promising cell therapy to market.
